[PTGX] YoY Annual Result on 31-Dec-2021 [#FY]

Stock
[PTGX] Protagonist Therapeutics, Inc.
Announcement Date
28-Feb-2022
Financial Year
2021
Quarter
31-Dec-2021 [#FY]
Profit Trend
YoY- -85.38%
Quarter Report
PTGX's Result
PTGX's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 60,000 26,581 27,357 28,628 231 30,925 20,063 20.02%
PBT -78,955 -127,393 -125,551 -64,845 -77,878 -39,723 -36,957 13.48%
Tax 0 -3,980 -2,924 1,305 -691 -799 -406 -
NP -78,955 -123,413 -122,627 -66,150 -77,187 -38,924 -36,957 13.48%
Tax Rate - - - - - - - -
Total Cost 138,955 149,994 149,984 94,778 77,418 69,849 57,020 15.99%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -131.59 -464.29 -448.25 -231.07 -33,414.29 -125.87 -184.20 -5.44%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -1.39 -2.52 -2.65 -1.92 -2.98 -1.74 -2.09 -6.56%
EPS Diluted -1.39 -2.52 -2.65 -1.92 -2.98 -1.74 -2.09 -6.56%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.